Skip to main content
. 2015 Feb 13;31(4):221–225. doi: 10.1016/j.joa.2014.12.008

Table 3.

Baseline parameters of responders and non-responders.

Responder (n=6) Non-responder (n=23) p-Value
Age, y 69±7 66±12 0.85
Male, n 4(67%) 13(56%) 0.55
Ischemic cardiomyopathy, n 3(50%) 5(22%) 0.14
LBBB, n 4(67%) 9(39%) 0.39
QRS width, ms 181±22 160±41 0.21
Paroxysmal AF, n 1(2%) 8(35%) 0.24
Persistent AF, n 0 5(22%)
Inotropes, n 3(50%) 14(61%) 0.79
Creatinine >1.5 mg/dL, n 3(50%) 7(30%) 0.41
Systolic BP, mmHg 96±14 97±16 0.97
LVEF, % 22±5 23±6 0.44
LVEDV, mL 219±66 189±78 0.38
LVESV, mL 184±56 142±63 0.21
MR, degree 1.5±0.6 1.6±0.5 0.51
LV dyssynchrony, ms 341±48 206±80 0.02
BNP, pg/mL 714±358 1352±823 0.06
Sodium, mmol/L 135±3 135±5 0.98
Hemoglobin, g/dL 12.6±1.3 10.2±1.8 0.07

LBBB, left bundle branch block; AF, atrial fibrillation; BP, blood pressure; LVEF, left ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; MR, mitral regurgiation; BNP, brain natriuretic peptide.